BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29477297)

  • 1. Chronic Lymphocytic Leukemia: A Review of Front-line Treatment Options, With a Focus on Elderly CLL Patients.
    O'Reilly A; Murphy J; Rawe S; Garvey M
    Clin Lymphoma Myeloma Leuk; 2018 Apr; 18(4):249-256. PubMed ID: 29477297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy.
    Small S; Ma S
    Curr Hematol Malig Rep; 2021 Aug; 16(4):325-335. PubMed ID: 34021874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia.
    Byrd JC; Stilgenbauer S; Flinn IW
    Hematology Am Soc Hematol Educ Program; 2004; ():163-83. PubMed ID: 15561682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lymphocytic leukemia: a clinical review.
    Nabhan C; Rosen ST
    JAMA; 2014 Dec; 312(21):2265-76. PubMed ID: 25461996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on chronic lymphocytic leukemia: a Pharma Matters report.
    D'Souza P; Walker G
    Drugs Today (Barc); 2014 Jul; 50(7):485-501. PubMed ID: 25101331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Lymphocytic Leukemia in the Elderly, Which Investigations Are Necessary: A Map for the Practicing Oncologist.
    Pinilla-Ibarz J; Emole J
    Cancer Control; 2015 Oct; 22(4 Suppl):7-16. PubMed ID: 26618341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How I treat chronic lymphocytic leukemia in older patients.
    Heraly B; Morrison VA
    J Geriatr Oncol; 2015 Sep; 6(5):333-40. PubMed ID: 26343987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Lymphocytic Leukemia: Current Concepts.
    Yu EM; Kittai A; Tabbara IA
    Anticancer Res; 2015 Oct; 35(10):5149-65. PubMed ID: 26408673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Chronic Lymphocytic Leukemia in the Elderly.
    Barrientos JC
    Cancer Control; 2015 Oct; 22(4 Suppl):17-23. PubMed ID: 26618342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of pharmacologic options for previously untreated chronic lymphocytic leukemia.
    Wilhelm K; Yang D
    J Oncol Pharm Pract; 2011 Jun; 17(2):91-103. PubMed ID: 20085962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment options in chronic lymphocytic leukemia.
    Montserrat E
    Hematol J; 2004; 5 Suppl 1():S2-9. PubMed ID: 15079148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel agents in chronic lymphocytic leukemia: efficacy and tolerability of new therapies.
    Lin TS
    Clin Lymphoma Myeloma; 2008 Aug; 8 Suppl 4():S137-43. PubMed ID: 18952544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and management of chronic lymphocytic leukemia in the elderly: what the pharmacist clinician should know.
    Johnson TM
    Consult Pharm; 2012 Apr; 27(4):274-85. PubMed ID: 22498987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemia.
    Reagan JL; Castillo JJ
    Future Oncol; 2014 May; 10(7):1147-55. PubMed ID: 24947256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic lymphocytic leukaemia: current management].
    Aurran-Schleinitz T; Arnoulet C; Ivanov V; Coso D; Rey J; Schiano JM; Stoppa AM; Bouabdallah R; Gastaut JA
    Rev Med Interne; 2008 May; 29(5):424-35. PubMed ID: 18359538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Front-line therapy for chronic lymphocytic leukemia.
    Desai S; Pinilla-Ibarz J
    Cancer Control; 2012 Jan; 19(1):26-36. PubMed ID: 22143060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of monoclonal antibody therapy for chronic lymphocytic leukemia.
    Nabhan C; Dyer MJ; Rosen ST
    Oncology (Williston Park); 2003 Feb; 17(2):253-62; discussion 264, 267, passim. PubMed ID: 12632866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
    Maddocks K; Jones JA
    Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.